Lorena López-González

552 total citations
32 papers, 391 citations indexed

About

Lorena López-González is a scholar working on Economics and Econometrics, Immunology and Oncology. According to data from OpenAlex, Lorena López-González has authored 32 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Lorena López-González's work include Lung Cancer Research Studies (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Lorena López-González is often cited by papers focused on Lung Cancer Research Studies (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Lorena López-González collaborates with scholars based in United States, Spain and Canada. Lorena López-González's co-authors include Robert A. Hummer, Robert Crosnoe, Emily Durden, Richard Barron, Paul Juneau, Lionel Pinto, Chandra Muller, Raynard Washington, Gary Pickens and J Langer and has published in prestigious journals such as Blood, Social Forces and Clinical Therapeutics.

In The Last Decade

Lorena López-González

31 papers receiving 378 citations

Peers

Countries citing papers authored by Lorena López-González

Since Specialization

Citations

This map shows the geographic impact of Lorena López-González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena López-González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena López-González more than expected).

Fields of papers citing papers by Lorena López-González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena López-González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena López-González. The network helps show where Lorena López-González may publish in the future.

Co-authorship network of co-authors of Lorena López-González

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena López-González. A scholar is included among the top collaborators of Lorena López-González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena López-González. Lorena López-González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LONG-TERM PROPHYLACTIC TREATMENT PREFERENCES OF PATIENTS WITH HEREDITARY ANGIOEDEMA 2024 ·Annals of Allergy Asthma & Immunology ·(unknown), (unknown), C. Olson, Thomas L. Ray, Lorena López-González, Pieter Gillard, Sandra Nestler-Parr, Christine Poulos, Marco Lionetti	1
2	Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy 2023 ·Advances in Therapy ·Jerome H. Goldschmidt, Lowell L. Hart, Jeffrey A. Scott, (unknown), (unknown), Trevor Heritage, Lorena López-González, Zheng‐Yi Zhou, (unknown), (unknown), Augustina Ogbonnaya, Kathryn A. DeYoung, (unknown), (unknown), (unknown), Huan Huang, Paul Conkling, Lucio Gordan	3
3	Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18–64 Years During the 2019–2020 US Influenza Season 2023 ·Open Forum Infectious Diseases ·Mahrukh Imran, (unknown), Justin R. Ortiz, Lorena López-González, (unknown), Machaon Bonafede, Mendel Haag	2
4	Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices 2023 ·Cancer Medicine ·Lowell L. Hart, Augustina Ogbonnaya, (unknown), Kathryn A. DeYoung, (unknown), Trevor Heritage, Lorena López-González, Huan Huang, Lucio Gordan	7
5	Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer Treated with Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices 2022 ·Lowell L. Hart, Augustina Ogbonnaya, (unknown), Kathryn A. DeYoung, (unknown), Trevor Heritage, Lorena López-González, Huan Huang, Lucio Gordan	1
6	Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with ES- SCLC in US Community Oncology Settings 2022 ·Jerome H. Goldschmidt, (unknown), Ping Shi, (unknown), Lorena López-González, Huan Huang, Paul Conkling	1
7	Real-world biologic and apremilast treatment patterns in patients with psoriasis and psoriatic arthritis 2021 ·Dermatology Online Journal ·Steven R. Feldman, Jingchuan Zhang, (unknown), Lorena López-González, Elizabeth Marchlewicz, (unknown), Yang Zhao, Alan M. Mendelsohn	3
8	Economic Burden of Growth Hormone Deficiency in a US Pediatric Population 2021 ·Journal of the Endocrine Society ·Paul B. Kaplowitz, Janna Manjelievskaia, Lorena López-González, (unknown), Pisit Pitukcheewanont, Alden Smith	2
9	Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States 2018 ·Clinical Therapeutics ·Xinke Zhang, Xue Song, Lorena López-González, (unknown), (unknown), Ze Cong	4
10	Economic burden associated with adverse events of special interest in patients with relapsed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in the United States 2018 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Xinke Zhang, Xue Song, Lorena López-González, (unknown), Ze Cong	6
11	Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions 2018 ·Cardiovascular Drugs and Therapy ·Susan Boklage, (unknown), Lorena López-González, Yao Ding, Caroline Henriques, Joseph Elassal	8
12	Economic Burden of Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Acute Lymphoblastic Leukemia (ALL) in the US 2017 ·Blood ·Xinke Zhang, Xue Song, Lorena López-González, (unknown), Ze Cong	1
13	Economic Burden of Veno-Occlusive Disease (VOD) in Patients with Acute Lymphoblastic Leukemia (ALL) in the US 2017 ·Blood ·(unknown), Xue Song, Lorena López-González, (unknown), (unknown), Ze Cong	1
14	Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States 2017 ·Archives of Osteoporosis ·Emily Durden, Lionel Pinto, Lorena López-González, Paul Juneau, Richard Barron	79
15	Racial and Ethnic Disparities in Health Among Employees at Large Firms 2015 ·Journal of Occupational and Environmental Medicine ·Rachel Mosher Henke, Lorena López-González, Degang Wang, Ron Z. Goetzel, (unknown), (unknown), (unknown)	2
16	Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States 2015 ·Journal of Medical Economics ·Emily Durden, (unknown), Lorena López-González, Mette Hammer, J Langer	16
17	Characteristics of Medicaid and Uninsured Hospitalizations, 2012 2014 ·Lorena López-González, Gary Pickens, Raynard Washington, Audrey J Weiss	10
18	Characteristics of Medicaid and Uninsured Hospitalizations, 2012: Statistical Brief #182 2006 ·Lorena López-González, (unknown), Reynold Washington, (unknown)	9
19	Immigration from Mexico, School Composition, and Adolescent Functioning 2005 ·Sociological Perspectives ·Robert Crosnoe, Lorena López-González	28
20	Immigrant Acculturation, Gender and Health Behavior: A Research Note 2005 ·Social Forces ·Lorena López-González, (unknown), Robert A. Hummer	117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact